The landscape of the global peripheral vascular devices market has been a dynamic one, marked by the COVID-19 impact, concerns regarding late mortality associated with certain devices, and emerging trends in medical treatment. These factors have influenced market expectations, clinical practices, and the development of innovative solutions in the field of vascular healthcare. Throughout this blog, we are going to discuss the controversial aspects of the global Peripheral Vascular device market, exploring several global trends and market shifts.
Recovery and Innovation in the DCB Market
Despite initial concerns following the Katsanos meta-analysis in 2018, the Drug-Coated Balloon (DCB) market is anticipated to witness a significant recovery over the forecast period. Most regions are expected to show growth similar to pre-2019 estimates, albeit slightly reduced. Recent clinical data has addressed some safety concerns around the long-term use of paclitaxel in peripheral devices. However, emphasis has shifted towards innovating non-paclitaxel balloons and stents, with ongoing developments and approvals in regional markets.
Stent Grafts: Dominance and Controversies
In 2023, stent grafts held the largest share in the global peripheral vascular device market. However, guidelines published by the National Institute of Health and Care Excellence (NICE) in 2020 in the U.K. regarding endovascular aortic aneurysm repair (EVAR) for pre-ruptured aneurysms sparked significant controversy. The debate prompted the final guidelines to recommend discussing all available treatment options with the patient. While the direct impact on the stent graft market might be limited, global concerns about EVAR’s long-term efficacy could lead to more stringent policies, potentially affecting the market’s value.
Trends in Medical Practices: Shifting Preferences and Procedures
A noticeable trend among physicians in the global peripheral vascular devices market involves minimizing the use of permanent devices within patients. This shift arises from the need for frequent follow-up treatments to address issues like thrombi in stents, and the consideration of limiting future treatment options. Consequently, there has been a rise in Drug-Coated Balloon (DCB) and atherectomy procedures across various regions.
Additionally, there’s a noticeable shift in the utilization of Drug-Eluting Stents (DESs) and covered stents in cases where device placement is deemed necessary. While these alternatives are notably more expensive, they offer potential solutions to address the challenges of follow-up treatments and provide a certain degree of flexibility in patient care. Interestingly, this shift is contributing to a net upward growth in the peripheral vascular stent market, despite the overall trend moving away from the traditional use of these devices in favor of DCBs and atherectomy treatments. The versatility and efficacy of DESs and covered stents are fostering their adoption, thereby balancing the market dynamics and contributing to the evolving landscape of peripheral vascular devices.
Conclusion: Global Peripheral Vascular Devices Market
The global peripheral vascular devices market continues to evolve amidst ongoing controversies, emerging clinical data, and shifting medical preferences. Innovations, coupled with revised guidelines and changing medical practices, are influencing the trajectory of various device segments. As the industry navigates these challenges, adaptability and innovation remain crucial for the development and adoption of safer, more effective peripheral vascular devices.
